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In the end of 2013, an official response was issued to ad-
dress reports by the local media that several children had 
died following vaccination with the hepatitis B vaccine. 
Such reports had aroused considerable suspicion from the 
public regarding the safety and quality of vaccines. The 
State Food and Drug Administration (SFDA) decided to 
temporarily suspend the use of the hepatitis B vaccine man-
ufactured by Shenzhen Kangtai Biological Products Co., 
Ltd. The withdrawal of this vaccine only heightened public 
concern about potential “unqualified vaccines” manufac-
tured by Kangtai. When issuing the above decision, the 
SFDA announced that it would take approximately 20 days 
to complete testing and to issue the final results. The fallout 
from this event could be damaging for other immunization 
programs, as public confidence in the effectiveness and 
need for vaccination strategies wanes. A joint statement 
issued by the SFDA and National Health And Family Plan-
ning Commission on January 3, 2014 stated no quality is-
sues were found for the hepatitis B vaccine manufactured by 
Kangtai. In addition, of the 17 deaths linked to vaccination 
with the hepatitis B vaccine, nine deaths were confirmed to 
have no association with the vaccine, whilst preliminary di-
agnosis of the remaining eight cases suggests their death is 
also unrelated to the vaccine. The scope of the impact result-
ing from public suspicion of the hepatitis B vaccine and im-
munization programs on the whole, cannot be underestimated. 
This event highlights the need and urgency for China to im-
prove their efforts in risk communication. 
In short, we should adopt a calm, non-emotive and logi-
cal approach in our assessment of this event. We should not 
implement changes to the national vaccination program 
based on a single “media-misleading” event. A review of 
vaccine development yielded records of human variolation 
for smallpox prevention in a number of Chinese history 
books, but the smallpox vaccination invented by a British 
doctor, Edward Jenner, has been universally regarded as the 
origin of vaccination and current immunology. Thanks to 
Jenner’s invention, smallpox has been eradicated, and im-
munology (a relatively new scientific branch) was devel-
oped. Immunology has played a significant role in control-
ling pathogenic microorganisms and tumors. Vaccines de-
veloped against various pathogenic microorganisms have 
invariably saved numerous lives, in both developed and 
developing countries. The national immunization program 
implemented in China includes 14 vaccines against 15 in-
fectious diseases, and to date it has played an integral role in 
disease prevention and control in China. Therefore, the ef-
fectiveness of vaccines and the necessity for immunization 
in disease control and prevention should not be overlooked 
because of this one event.  
In general, increasing suspicion and lack of confidence in 
vaccine immunizations are occurring globally. Resistance to 
vaccination with PDT (pertussis, diphtheria, and tetanus) 
and/or measles vaccines in the Great Britain resulted in an 
increase in reportable pertussis and measles cases. The topic 
for World Immunization Week (the last week in April of 
every year) is as follows: “understand the situation and 
conduct vaccination”. The purpose of setting up World 
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Immunization Week is to highlight the roles played by vac-
cines in preventing and controlling infectious diseases.    
Hepatitis B vaccine events do provide warnings and sev-
eral suggestions for future work, which are presented as 
follows: 
(i) The media and management should address how they 
communicate serious health risks to the public. In particular, 
all information communicated to the public should be based 
on facts to avoid inciting panic. Recent discussions on ge-
netically modified organisms highlight such a lack of ra-
tional communication. We need to better educate the public 
on the historical role of vaccines, and the critical roles of 
vaccines in disease control and prevention. In most cases, 
vaccination confers a lifetime protection against diseases.  
(ii) We should establish a national vaccine adverse reac-
tion database. Municipalities and provinces with sound in-
formation infrastructure, such as Shanghai and Zhejiang, 
should take the lead in the establishment of such a database; 
with the intention of extending this throughout the whole 
country. 
(iii) We should establish an honest and reliable confirma-
tion and compensation mechanism for adverse reactions.  
This would hopefully renew public confidence in research 
related to vaccine production, circulation, management, 
inoculation and follow-up services. 
(iv) In general, there is a lack of public knowledge (pub-
lic understanding of science) of vaccines and immunization, 
whilst scientific dissemination of vaccines by researchers 
and producers is of reduced importance. It is hoped that by 
making available more scientific-based literature on vac-
cines to the wider community, the lay-person would devel-
op a greater understanding of the importance of vaccines in 
disease control and prevention, and consequently the need 
for further research in this area.  
(v) A nationwide epidemiological survey of hepatitis B 
infection should be undertaken, as the last study was con-
ducted in 1992. We hope that the relevant departments can 
take prompt action to thoroughly investigate the current 
domestic epidemics and infections, strengthen the relevant 
basic research and adjust immunization strategies based on 
sound scientific data. We should consider whether the cur-
rent immunization strategies (programs) are practical for a 
hepatitis B negative family whose child will be vaccinated 
within 24 h after birth, and whether the time of this first 
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